BioWorks 8: AI-Driven Drug Discovery with Alex Zhavoronkov

In this conversation, Alex Zhavoronkov, founder and CEO of Insilico Medicine, dives into the transformative power of AI in drug discovery, discussing everything from target identification to speeding up clinical trials. He shares his unique journey from computer science to biotech, emphasizing the vital role of deep learning in tackling age-related diseases. Alex introduces the concept of 'pandaomics' for understanding gene networks and highlights the importance of interdisciplinary teams in innovation. He also shares insights on personal growth and the future of biotech.